Low‐Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System

John N. Mafi,Folasade P. May,Katherine L. Kahn,Michelle C. Chong,Edgar Corona,Liu Yang,Margaret M. Mongare,Vishnu Nair,Courtney Reynolds,Reshma Gupta,Cheryl L. Damberg,Eric Esrailian,Catherine A. Sarkisian

Low‐Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System

2019

John N. Mafi
Folasade P. May
Katherine L. Kahn
Michelle C. Chong
Edgar Corona
Liu Yang
Margaret M. Mongare
Vishnu Nair
Courtney Reynolds
Reshma Gupta
Cheryl L. Damberg
Eric Esrailian
Catherine A. Sarkisian

Background: Older adults are particularly vulnerable to complications from proton pump inhibitor (PPI) drugs. We sought to characterize the prevalence of potentially low-value PPI prescriptions among older adults in order to inform a quality improvement (QI) intervention.

Keywords:

Deprescribing
Diabetes mellitus
Geriatrics
Physical therapy
Intensive care medicine
Proton-pump inhibitor
Medical prescription
Medicine
GERD
medication list
Cohort
Guideline
Internal medicine
Gastrointestinal bleeding

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations